Uploaded August 2026 | Updated September 2026, 2 weeks ago
Dr. Ethan Russo (CReDO Science) presents "Cannabis and Psychiatry: Pros and Cons throughout Human Development" at CannMed 2026, covering cognitive impairment, depression, anxiety, and psychosis.
This presentation examines cognitive impairment related to cannabis, and the benefits and liabilities related to depression, anxiety, and psychosis.
Dr. Ethan Russo, MD is the Founder and CEO of CReDO Science.
This talk was part of the CannMed Medical Practicum, a full-day educational program for clinicians and professionals expanding their expertise in medical cannabis, covering the endocannabinoid system, cannabinoid therapeutics, minor cannabinoids, product formulation, and more, led by a faculty of internationally recognized physicians and researchers.
This presentation was given at the CannMed 2026 Innovation & Collaboration Summit, held June 15-18 at the Hyatt Regency Lake Tahoe Resort. Visit cannmedevents.com to learn more.
Dr. Ethan Russo (CReDO Science) presents "Cannabis and Psychiatry: Pros and Cons throughout Human Development" at CannMed 2026, covering cognitive impairment, depression, anxiety, and psychosis.
This presentation examines cognitive impairment related to cannabis, and the benefits and liabilities related to depression, anxiety, and psychosis.
Dr. Ethan Russo, MD is the Founder and CEO of CReDO Science.
This talk was part of the CannMed Medical Practicum, a full-day educational program for clinicians and professionals expanding their expertise in medical cannabis, covering the endocannabinoid system, cannabinoid therapeutics, minor cannabinoids, product formulation, and more, led by a faculty of internationally recognized physicians and researchers.
This presentation was given at the CannMed 2026 Innovation & Collaboration Summit, held June 15-18 at the Hyatt Regency Lake Tahoe Resort. Visit cannmedevents.com to learn more.
